Stock Taper
SHC
SOTERA HEALTH COMPANY
NASDAQ
$19.27
▼ DOWN 1.08% (-0.21)

KEY STATISTICS

Market Cap$5.50 B
52w High$19.85
52w Low$13.09
Dividend Yield
Frequency
P/E20.07
Volume1.39M
Shares Out.285.17M

COMPANY

LEADERSHIP

Alton E. Shader
CHIEF EXECUTIVE
Alton E. Shader

COMPENSATION 2026

Salary$1,130,699
Stock Awards$8,022,400
Incentive Plan Pay$1,484,890
All Other Comp.$18,074
Total$10,656,063

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 20, 2020
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
3,000

PRICE TARGET

Target High$20.00
Target Low$18.00
Target Median$19.00
Target Consensus$19.00

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$319.84M
NOV
3
TUE

PRICE

$19.27 ▼ DOWN 1.08% (−$0.21)
$19.30$19.35$19.40$19.459:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM19.27

About Sotera Health Company

https://soterahealth.com ↗

Sotera Health provides sterilization, lab testing, and advisory services for medical, pharmaceutical, food, and industrial industries across the US, Canada, Europe, and globally.

INDUSTRY

Medical - Diagnostics & Research

A SERVICE SOTERA HEALTH COMPANY IS KNOWN FOR

Sterilization and Laboratory Testing Services

Sotera Health, via Sterigenics and Nelson Labs, provides sterilization solutions and laboratory testing to ensure the safety and compliance of medical devices, pharmaceuticals, and other products.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Service$255.53M $259.04M $241.61M $278.32M
Product$55.78M $44.4M $38.44M $43.05M

Revenue by Geography

MapREGIONFY2022FY2023FY2024FY2025
UNITED STATES$579.02M $590.97M $616.68M $629.54M
Europe$166.03M $187.54M $196.01M $232.18M
CANADA$188.74M $192.05M $208.89M $221.95M
Other Geographical Areas$69.9M $78.73M $78.86M $79.95M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets4
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR, OFFICER: EXECUTIVE CHAIRMAN
Petras Michael B. Jr.
Sale · 294.5K shares
2026-08-17
DIRECTOR, OFFICER: EXECUTIVE CHAIRMAN
Petras Michael B. Jr.
Sale · 850.0K shares
2026-08-17
OFFICER: PRESIDENT OF STERIGENICS
Rutz Michael P
Sale · 150.0K shares
2026-08-07
OFFICER: SR. VICE PRESIDENT, CFO
Lyons Jonathan M.
Sale · 11.3K shares
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 2
BUY 2
NEUTRAL 1
5 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
GKOS$179.87COMPARE
PTGX$144.33COMPARE
ALKS$47.41COMPARE
OSCR$30.47COMPARE
TFX$139.67COMPARE
BLCO$17.15COMPARE
MMSI$90.49COMPARE
OPCH$23.90COMPARE